8-K current report · filed Nov 13, 2026

Adicet Bio Inc (ACET) 8-K Current Report: November 13, 2026

Item 5.02ACET overview

Short answer

Adicet Bio Inc (ACET) filed an 8-K current report with the SEC on November 13, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Director Andrew Sinclair resigned November 13, 2026 from the Board, Audit Committee and NCG Committee.

Adicet Bio Inc 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Director Andrew Sinclair resigned November 13, 2026 from the Board, Audit Committee and NCG Committee
  • Board size reduced from seven to six, with no reported disagreement driving Sinclair’s departure
  • Michael Grissinger appointed to the Audit Committee, preserving an independent audit committee member
  • Grissinger named NCG Committee chairperson, strengthening board governance continuity

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Adicet Bio Inc 8-K filings

Get the next ACET 8-K as it lands

Follow ACET for push alerts, or ask the research agent what this filing means.